Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 06 May 2022 |
2 | Reply to Exam Report (MIS-R) | 18 Aug 2022 |
3 | Journal Copy | 10 Feb 2023 |
4 | TM-O(NOTICE OF OPPOSITION) | 14 Apr 2023 |
5 | Annexure -1 under rule 46 | 26 Sep 2023 |
5 | Evidence Affidavit Under Rule 46 (TOP) | 26 Sep 2023 |
6 | Annexure -1 under rule 46 | 26 Sep 2023 |
6 | Evidence Affidavit Under Rule 46 (TOP) | 26 Sep 2023 |
1 | EXAMINATION REPORT | 13888361 | 03 Aug 2022 | |
2 | Opposition Notice | 15175279 | 5937232 | 01 May 2023 |
3 | Opposition Counter Statement | 15508388 | 6028080 | 27 Jun 2023 |
The application for Solcer was made on 06 May 2022.
The trademark applicant for Solcer is STRIDES PHARMA SCIENCE.
Solcer is applied in class(es) 5.
Application for Solcer is on Opposed stage.
Application Id allotted to Solcer is 5437906.
Trademark agent or attorney for the application is Altacit Global.
Solcer filed with the Intellectual property office as a WORD.